Document is current
Any future updates will be listed below
-
Authors
Fisher, Richard
Moore, Gary W.
Mitchell, Michael J.
Dai, Letian
Crichton, Siobhan
Lumlertgul, Nuttha
Ostermann, Marlies https://orcid.org/0000-0001-9500-9080
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02486614 at ClinicalTrials.govDocuments that mention this clinical trial
Effects of regional citrate anticoagulation on thrombin generation, fibrinolysis and platelet function in critically ill patients receiving continuous renal replacement therapy for acute kidney injury: a prospective study
https://doi.org/10.1186/s13613-022-01004-w
- License Information
-
More Information
Article History
Received: 5 November 2021
Accepted: 18 March 2022
First Online: 31 March 2022
Declarations
:
: Full ethical approval was granted by the London—Harrow National Research Ethics Committee (14/LO/0138). Informed consent to participate in the study was provided by the patient if possible. If the patient did not have capacity to consent, a personal or professional legal consultee was consulted and informed consent was obtained from the legally accepted representative of the patient. In all patients who survived, informed consent to remain in the study was sought following patient recovery. To generate local reference ranges for the TGA measurements, healthy volunteers provided samples. The department has an accredited normal donor management system where informed written consent is obtained prior to sample donation.
: Informed consent for publication of the results was provided by the participants if possible. If the patient did not have capacity to consent, a personal or professional legal consultee was consulted and informed consent was obtained from the legally accepted representative of the patient. In all patients who survived, informed consent to remain in the study was sought following patient recovery.
: MO has received speaker honoraria and research funding from Fresenius Medical and Baxter and is a member of an advisory board for NxStage and Pfizer. GWM reports consultancy fees from Technoclone and was employed at Guy's & St Thomas' Hospital at the time of the study. RF, MM, LD, SC and NL report no conflict of interest.
